Paris-based Implicity, founded in 2016 by electrophysiologist Dr. Arnaud Rosier, has raised a €35 million (~$37.8M) funding round led by European tech growth firm IRIS alongside Five Arrows, the alternative assets arm of Rothschild & Co. The article does not characterize the financing as a first round, Series, or follow-on. The company said it will use the capital to accelerate international expansion, particularly in the U.S., while advancing its AI capabilities and developing next-generation heart failure prediction algorithms for its universal platform monitoring cardiac implantable electronic devices (CIEDs) and heart failure patients. No specific metrics on clients, revenue, pipeline, or employee count were disclosed in the article.